Research only

Pharmaceutical and biotechnology manufacturers

Explore the policy documents and regulatory sources relevant to this industry. Assessment checks for this profile are in development.

Research listings are separate from implemented scans. No quote or assessment is available for this profile yet. Public uploads must contain no patient data or other restricted information.

Documents to review

  • Manufacturing SOPResearch document type
  • Quality manualResearch document type
  • Deviation procedureResearch document type
  • Capa procedureResearch document type
  • Validation procedureResearch document type

Scope questions

Industry alone does not establish legal applicability. Confirm location, activities, role, data and relevant thresholds.

  • Where does the organization operate, and which regulator, license, permit or contract governs the activity?
  • Which business activities, data types and organization roles does the document describe?
  • Do the relevant thresholds or exceptions change which requirements apply?

Unknown answers stay unresolved. Document detection does not answer these questions for you.

A fictional example to explore

This short policy outline demonstrates the document's structure and research questions. It is a navigation example; scans for this profile are not available yet.

PDF pages are counted exactly. DOCX and TXT use the disclosed word-count estimate, so the same policy can have different billable page counts.

Regulations and frameworks to explore

These are research candidates for this profile. Confirm the exact organization and activity before concluding that a rule applies.

Research only

Drug manufacturing current good manufacturing practice

21 CFR Parts 210 and 211

For drug manufacturing and related operations within the applicable FDA CGMP regime. Parts 210 and 211 address finished pharmaceuticals; product type and operations can require other provisions. FDA production/process Q&A is nonbinding guidance, not the complete rule. Distinguish manufacturer, contract operation and outsourcing roles before choosing checks.

Jurisdictions: US-FEDERAL

Research applicability questions
  • What drug product and manufacturing, packaging, testing or holding operations are performed?
  • Is the organization the manufacturer, contract facility or an outsourcing operation with its own applicable regime?
Research only

FDA electronic records and signatures

21 CFR Part 11

Applies to electronic records and signatures within the scope of FDA predicate-rule record requirements and qualifying electronic submissions. It is not a universal rule for every electronic business document. Identify the predicate rule, record/signature use and system before assessing requirements.

Jurisdictions: US-FEDERAL

Research applicability questions
  • Which FDA predicate rule requires these records to be maintained or submitted?
  • Are required records maintained/submitted electronically rather than only paper records or convenience copies?
  • Are electronic signatures used in place of signatures required by the applicable FDA rules?
Research only

OSHA emergency action plans

29 CFR 1910.38

An emergency action plan is required when another OSHA standard triggers 29 CFR 1910.38. Confirm the triggering standard and state-plan coverage. A plan must generally be written and available to employees; employers with ten or fewer employees may communicate it orally. Do not infer a written-plan violation solely from the industry label.

Jurisdictions: US-FEDERAL

Research applicability questions
  • Which OSHA standard requires an emergency action plan for this workplace?
  • How many employees does the employer have, and does the ten-or-fewer oral-plan exception apply?
  • Does an OSHA-approved state plan apply, and does it impose different workplace requirements?
  • What work activities, hazards and other OSHA standards trigger this workplace emergency-plan duty?
Research only

RCRA hazardous-waste management

40 CFR Parts 260–273; select generator, transporter and facility provisions

For activities involving wastes classified as hazardous under the applicable federal/state RCRA program. Generator category, accumulation, transport, treatment/storage/disposal and permit status determine requirements. Authorized state programs can be broader or more stringent. An industrial-sector label or a recycling operation alone does not establish every hazardous-waste duty.

Jurisdictions: US-FEDERAL

Research applicability questions
  • What hazardous-waste determinations and generator, transporter or treatment/storage/disposal roles apply?
  • Which federal or authorized-state program, generator category, exclusions and permits govern the facility?